Ameritas Investment Partners’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Ameritas Investment Partners’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-800	Closed	-$3K	–	3283
2021 Q1	$3K	Hold	800	–	–	﹤0.01%	3067
2020 Q4	$3K	Hold	800	–	–	﹤0.01%	3040
2020 Q3	$4K	Hold	800	–	–	﹤0.01%	3029
2020 Q2	$5K	Hold	800	–	–	﹤0.01%	2974
2020 Q1	$3K	Hold	800	–	–	﹤0.01%	2935
2019 Q4	$6K	Hold	800	–	–	﹤0.01%	2889
2019 Q3	$3K	Hold	800	–	–	﹤0.01%	3000
2019 Q2	$3K	Hold	800	–	–	﹤0.01%	3000
2019 Q1	$3K	Hold	800	–	–	﹤0.01%	2926
2018 Q4	$6K	Buy	+800	New	+$6.4K	﹤0.01%	2834

Other funds holding RVLP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ameritas Investment Partners's RVLP Position: Q2 2021 in Review

Ameritas Investment Partners sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2021, closing a stake of 800 shares — an estimated $3K sold.

Ameritas Investment Partners first reported a position in RVLP in Q4 2018 and held it in 10 quarters. The position peaked at $6K in Q4 2019. 46 funds tracked by Wall St. Rank hold RVLP as of Q2 2021.

Ameritas Investment Partners reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 800 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2021, an estimated $3K.
Ameritas Investment Partners first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 10 quarters.
Ameritas Investment Partners's RVL Pharmaceuticals plc Ordinary Shares position peaked at $6K in Q4 2019.
46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.